About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.
Daily Archives: April 29, 2010
Communications and Marketing Implications of a Change in FDA Policy for Medical Device AdComms
In June of 2008, January of 2009 and again in June 2009 the General Accounting Office issued reports on the FDA and its oversight of medical devices. The June 2009 report echoed findings from the earlier January report, put forth a recommendation … Continue reading
Posted in Advisory Committee Prepapartion, FDA Policy
Comments Off on Communications and Marketing Implications of a Change in FDA Policy for Medical Device AdComms